About
TRiCares GmbH is a medical device company based in Aschheim/Munich, Germany, with additional offices in Paris, the US, and Brazil. The company focuses on treating severe tricuspid regurgitation (TR), a heart valve disease affecting millions globally. TRiCares is developing Topaz, a minimally invasive transfemoral tricuspid valve replacement (TTVR) system that aims to provide an effective alternative to open-heart surgery. This system features a dual stent design and a low-profile catheter for easy implantation via the femoral vein. Currently, TRiCares is conducting clinical trials, including an Early Feasibility Study in the US and Canada, to assess the safety and performance of the Topaz system. The company is led by experienced professionals, including President and CEO Ahmed Elmouelhi, who has over 20 years in the medical device industry. TRiCares has raised significant funding, including $50 million in Series D financing, to support its mission of improving treatment options for patients with severe TR.
Technologies
Keywords
Company Information
-
Employees 36
-
Founded 2013
-
Annual Revenue $6000000
-
Total Funding $126556885
Location
Aschheim, Bavaria, Germany, 85609
